Skip to content

Sharing successes, challenges and daily happenings in the Department of Medicine

Article of the Week

Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies

ARTICLE: Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies AUTHORS: Steven G Coca, George Vasquez-Rios, Sherry… Read More »Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies

Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants

 ARTICLE: Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants AUTHORS: Emily J Fray, Fengting Wu, Francesco R Simonetti, Carolin Zitzmann, Narmada Sambaturu, Carmen Molina-Paris, Alexandra… Read More »Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants

Clonally expanded HIV-1 proviruses with 5′-leader defects can give rise to nonsuppressible residual viremia

ARTICLE: Clonally expanded HIV-1 proviruses with 5'-leader defects can give rise to nonsuppressible residual viremia AUTHORS: Jennifer A White, Fengting Wu, Saif Yasin, Milica Moskovljevic, Joseph Varriale, Filippo Dragoni, Angelica Camilo-Contreras, Jiayi… Read More »Clonally expanded HIV-1 proviruses with 5′-leader defects can give rise to nonsuppressible residual viremia

Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus

ARTICLE: Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus AUTHORS: Thomas Dörner, Yoshiya Tanaka, Ernst… Read More »Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus